Omalizumab Patent Expiration
Omalizumab Large Molecule Patents
Given below is the list of large molecule patents protecting Omalizumab, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Xolair | USUS10034940 | High concentration antibody and protein formulations | Nov 04, 2025 | Genentech, Inc. |
| Xolair | USUS11987637 | Prevention of disulfide bond reduction during recombinant production of polypeptides | Jul 08, 2028 | Genentech, Inc. |
| Xolair | USUS12030959 | Anti-IgE antibody therapy for multiple food allergies | Jul 20, 2043 | Genentech, Inc. |
Omalizumab's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List